CSIMarket


Cryo cell International Inc   (CCEL)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare


 

Cryo cell International Inc

CCEL's Financial Statements and Analysis



Cryo cell International Inc reported in the third quarter of 2023 net earnings per share of $0.08 an increase by 33.33 % year on year from $0.06 and an improvement of 166.67 % from $0.03 realized in II. Quarter (May 31 2023).


third quarter of 2023
Earnings Per Share Revenues
$ 0.08 $  8 Mill
$+0.02     +33.33 % Unch.     +2.46 %



Cryo Cell International Inc 's Revenue rose by 2.46 % in third quarter of 2023 (Aug 31 2023) year on year, to $8 million and advanced by 1.25 % sequentially.


Cryo Cell International Inc is

More on CCEL's Income Statement



Cryo Cell International Inc 's net income of $0.681 million in the third quarter of 2023 increased by 45.79 % from net earnings of $0.467 million achieved in III. Quarter a year ago.

Sequentially net earnings grew by 207.98 % from net income of $0.221 million realized in previous quarter.

More on CCEL's Growth

Cryo Cell International Inc Inventories
Inventories grew by 15.62 % to $1 million from III. Quarter a year ago, sequentially inventories rose by 20.88 %. In Aug 31 2023 company's net cash and cash equivalents decreased by $-1 million, capital expenditures grew by -11.238863-70.72%, to $-3 millions compare to same quarter a year ago

More on CCEL's Cash flow Statement


Cryo cell International Inc payed out dividend of $0.91 per share in last 52 weeks representing 303.33 % of net earning per share in trailing twelve-month period.

During the same period Cryo cell International Inc earned $ 0.96 cash per share, on a free-cash flow basis 319.87 % of net earning per share.


Tangible Book value grew to $ -0.40 per share from $ -0.51.

Company issued 0.01 million shares or 0.12 % in Aug 31 2023.
Interest Coverage Ratio was 2.64. Debt Coverage Ratio was 0.55.

More on CCEL's Dividends

 Market Capitalization (Millions) 67
 Shares Outstanding (Millions) 8
 Total Debt (Millions $) 10
 Revenue (TTM) (Millions $) 31
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) -5
 Dividend TTM ($) 0.91 $
 Dividend Yield TTM (%) 11.32 %
 Employees (TTM) $ -




Cryo cell International Inc payed out dividend of $0.91 per share in the last 52 weeks representing 303.33 % of net earning per share in trailing twelve-month period.

During the same period Cryo cell International Inc had $ 0.96 cash flow per share, on a free-cash flow basis 319.87 % of net earning per share.


Tangible Book value grew to $ -0.40 per share from $ -0.51.

Company issued 0.01 million shares or 0.12 % in Aug 31 2023.
Interest Coverage Ratio was 2.64. Debt Coverage Ratio was 0.55.

More on CCEL's Balance Sheets

 Market Capitalization (Millions) 67
 Shares Outstanding (Millions) 8
 Total Debt (Millions $) 10
 Revenue (TTM) (Millions $) 31
 Net Income (TTM) (Millions $) 3
 Cash Flow (TTM) (Millions $) -2
 Capital Exp. (TTM) (Millions $) -5
 Dividend TTM ($) 0.91 $
 Dividend Yield TTM (%) 11.32 %
 Employees (TTM) $ -
   


  News about Cryo cell International Inc Earnings

Cryo Cell International Inc's Impressive 2.46% Growth Spurs Investor Activity in Q3 2023



Over the past five trading days, Cryo Cell International Inc has experienced a significant drop in its stock value. However, the company's year-to-date performance remains positive, and its financial results, released for the period ending August 31, 2023, indicate several positive developments. This article will analyze these financial results and evaluate their potential impact on the company's future.
1. Increasing Profitability:
Cryo Cell International Inc's profit per share has significantly increased by 33.33% to $0.08. In comparison to the previous year ($0.06 per share), this growth highlights the company's improving financial health. Additionally, the earnings per share (EPS) surge...

Cryo Cell International Faces Earnings Dip Despite 1.827% Revenue Boost in Q2 2023


Introduction:
Cryo Cell International Inc, a leading cellular therapy company, has reported its financial results for the period March to May 31, 2023. While the company witnessed a positive revenue advancement of 1.827%, it unfortunately experienced a significant income decline of -57.14% compared to the same reporting period the previous year. This article will analyze the key financial figures and assess the implications for Cryo Cell International Inc.
Financial Results Overview:
During the reported period, Cryo Cell International Inc generated revenue of $7.77 million, representing a marginal decrease of -0.661% compared to the prior reporting period. The earnings per share (EPS) stood ...


Date modified: 2023-10-13T11:42:24+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com